Omega 3 fatty acid supplementation after myocardial infarction: a systematic review and meta-analysis

Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks

(2018) Theingi Aung et al.   JAMA Cardiology

GRADE guidelines 17: assessing the risk of bias associated with missing participant outcome data in a body of evidence

(2017) Gordon H. Guyatt et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Effect of Omega-3 Acid Ethyl Esters on Left Ventricular Remodeling After Acute Myocardial InfarctionClinical Perspective

(2016) Bobak Heydari et al.   CIRCULATION

Fish-Derived Omega-3 Fatty Acids and Prostate Cancer: A Systematic Review

(2016) Monique Aucoin et al.   INTEGRATIVE CANCER THERAPIES

Effects of Omega-3 fatty acid on major cardiovascular events and mortality in patients with coronary heart disease: A meta-analysis of randomized controlled trials

(2013) Y.T. Wen et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Addressing Dichotomous Data for Participants Excluded from Trial Analysis: A Guide for Systematic Reviewers

(2013) Elie A. Akl et al.   PLoS One

Efficacy of Omega-3 Fatty Acid Supplements (Eicosapentaenoic Acid and Docosahexaenoic Acid) in the Secondary Prevention of Cardiovascular Disease

(2012) Seung-Kwon Myung   ARCHIVES OF INTERNAL MEDICINE

GRADE guidelines 6. Rating the quality of evidence—imprecision

(2011) Gordon H. Guyatt et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Eicosapentaenoic acid (EPA) from highly concentrated n−3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability

(2010) Abbie L. Cawood et al.   ATHEROSCLEROSIS

OMEGA, a Randomized, Placebo-Controlled Trial to Test the Effect of Highly Purified Omega-3 Fatty Acids on Top of Modern Guideline-Adjusted Therapy After Myocardial Infarction

(2010) Bernhard Rauch et al.   CIRCULATION

n–3 Fatty Acids and Cardiovascular Events after Myocardial Infarction

(2010) Daan Kromhout et al.   NEW ENGLAND JOURNAL OF MEDICINE

Comparison of Low-Fat Versus Mediterranean-Style Dietary Intervention After First Myocardial Infarction (from The Heart Institute of Spokane Diet Intervention and Evaluation Trial)††Conflicts of interest: Dr. Bibus has received consulting fees from companies that make fish oil, Coromega Co., Vista, CA, and Enreco, Inc., Newton, WI. He also has equity ownership in Lipid Technologies, LLC, Austin, MN, the company that performed the plasma fatty acid analysis. Dr. Bibus owns patents related to lipid therapy. He has served as an expert witness regarding lipids and fatty acids.

(2008) Katherine R. Tuttle et al.   AMERICAN JOURNAL OF CARDIOLOGY

Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial

(2008) GISSI-HF investigators   LANCET

What is “quality of evidence” and why is it important to clinicians?

(2008) Gordon H Guyatt et al.   BMJ-British Medical Journal